A Diagnostic for the Early Detection of Bladder Cancer

Running, not enrolling

Conditions studied: Bladder Cancer

In brief

To improve upon the non-invasive detection of bladder cancer by further validating a multiplex ELISA assay directed at a bladder cancer-associated diagnostic signature in voided urine samples of patients with a high risk of developing bladder cancer.

Key facts

Study ID
NCT05347342
Run by
Cedars-Sinai Medical Center
People needed
173
Starts
2022-04-29
Expected to finish
2029-01-01
Last updated by the study team
2026-02-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.